Cue Biopharma Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting

NEXT STORY
Cocrystal Pharma Announces New Data on CC-31244 and Abstract Acceptance for Poster Presentation at the AASLD 2019 Liver Meeting
PREV STORY
Cyclerion Therapeutics Announces Praliciguat Topline Phase 2 Results in Diabetic Nephropathy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioSig Technologies Launches New Corporate Website

Minneapolis, MN, June 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...

author_avatar
NASDAQ Market News

Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal® to the Oncology Market in United States

23 July 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US announces Co-Promotion ...

author_avatar
NASDAQ Market News

electroCore, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

BASKING RIDGE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR) today ...

author_avatar
NASDAQ Market News